These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estimating the cost of epilepsy in Europe: a review with economic modeling. Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267 [TBL] [Abstract][Full Text] [Related]
3. Cost of disorders of the brain in Europe 2010. Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J; Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589 [TBL] [Abstract][Full Text] [Related]
4. Cost of status epilepticus: A systematic review. Kortland LM; Knake S; Rosenow F; Strzelczyk A Seizure; 2015 Jan; 24():17-20. PubMed ID: 25564314 [TBL] [Abstract][Full Text] [Related]
5. Cost of illness for bipolar disorder: a systematic review of the economic burden. Kleine-Budde K; Touil E; Moock J; Bramesfeld A; Kawohl W; Rössler W Bipolar Disord; 2014 Jun; 16(4):337-53. PubMed ID: 24372893 [TBL] [Abstract][Full Text] [Related]
6. The direct cost of epilepsy in the United States: A systematic review of estimates. Begley CE; Durgin TL Epilepsia; 2015 Sep; 56(9):1376-87. PubMed ID: 26216617 [TBL] [Abstract][Full Text] [Related]
7. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review. Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330 [TBL] [Abstract][Full Text] [Related]
8. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review. Zemedikun DT; Kigozi J; Wynne-Jones G; Guariglia A; Roberts T PLoS One; 2021; 16(5):e0251406. PubMed ID: 33974661 [TBL] [Abstract][Full Text] [Related]
9. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review. Franklin M; Pollard D; Sah J; Rayner A; Sun Y; Dube F; Sutton A; Qin L Adv Ther; 2024 Jul; 41(7):2700-2722. PubMed ID: 38833143 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study. Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of costs of epilepsy using an electronic practice management software in Germany. Noda AH; Hermsen A; Berkenfeld R; Dennig D; Endrass G; Kaltofen J; Safavi A; Wiehler S; Carl G; Meier U; Elger CE; Menzler K; Knake S; Rosenow F; Strzelczyk A Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902 [TBL] [Abstract][Full Text] [Related]
12. A review of the costs of managing childhood epilepsy. Beghi E; Frigeni B; Beghi M; De Compadri P; Garattini L Pharmacoeconomics; 2005; 23(1):27-45. PubMed ID: 15693726 [TBL] [Abstract][Full Text] [Related]
13. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Gao L; Xia L; Pan SQ; Xiong T; Li SC Epilepsy Res; 2015 Feb; 110():146-56. PubMed ID: 25616467 [TBL] [Abstract][Full Text] [Related]
14. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview. Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671 [TBL] [Abstract][Full Text] [Related]
15. The global cost of epilepsy: A systematic review and extrapolation. Begley C; Wagner RG; Abraham A; Beghi E; Newton C; Kwon CS; Labiner D; Winkler AS Epilepsia; 2022 Apr; 63(4):892-903. PubMed ID: 35195894 [TBL] [Abstract][Full Text] [Related]
16. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718 [TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of seizures associated with solitary cysticercus granuloma. Murthy JM; Rajshekar G Neurol India; 2007; 55(1):42-5. PubMed ID: 17272898 [TBL] [Abstract][Full Text] [Related]
18. Methodological issues in estimating the cost of epilepsy. Begley CE; Annegers JF; Lairson DR; Reynolds TF Epilepsy Res; 1999 Jan; 33(1):39-55. PubMed ID: 10022365 [TBL] [Abstract][Full Text] [Related]
19. The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review. Burgos-Pol R; Martínez-Sesmero JM; Ventura-Cerdá JM; Elías I; Caloto MT; Casado MÁ Actas Dermosifiliogr; 2016 Sep; 107(7):577-90. PubMed ID: 27316590 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy. Luoni C; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Mazzucchelli I; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]